A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 98
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : VEGFRs
Long Form : VEGF receptors
No. Year Title Co-occurring Abbreviation
2020 Absence of VEGFR-1/Flt-1 signaling pathway in mice results in insensitivity to discogenic low back pain in an established disc injury mouse model. DDD, LBP, VEGF, WT
2020 Activation of VEGF receptors in response to UVB promotes cell proliferation and melanogenesis of normal human melanocytes. TA, UVB
2020 Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. CTLs, jRCT, MGMT, TMZ, VEGF
2020 Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. EC, ECM, RTK, VEGF
2020 Vascular Abnormalities and the Role of Vascular Endothelial Growth Factor in the Epileptic Brain. AEDs, BBB, VEGF
2019 Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation. ATM
2019 Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis. VEGF-A
2019 Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancer. CRC, mCRC, PlGF, sVEGFRs, VEGFs
2019 The clinical application of fruquintinib on colorectal cancer. CRC, EGFR, NSCLC, VEGF
10  2019 The discovery of the fundamental role of VEGF in the development of the vascular system. VEGF, VPF
11  2018 A Review on The Role of VEGF in Tamoxifen Resistance. ---
12  2018 Colorimetric immunoassays for the screening and specificity evaluation of molecules disturbing VEGFs/VEGFRs interactions. VEGFs
13  2018 Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2. VEGF-A
14  2018 Vascular endothelial growth factor signaling in development and disease. VEGFs
15  2018 VEGFR Recognition Interface of a Proangiogenic VEGF-Mimetic Peptide Determined In Vitro and in the Presence of Endothelial Cells by NMR Spectroscopy. VEGF
16  2017 A novel peptide specifically binding to VEGF receptor suppresses angiogenesis in vitro and in vivo. peptide HRH, VEGF
17  2017 Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer. GC, rhVEGF, VEGF
18  2017 Peroxisome proliferator‑activated receptor gamma mediates porcine placental angiogenesis through hypoxia inducible factor‑, vascular endothelial growth factor‑ and angiopoietin‑mediated signaling. Angs, HIFs, PPAR, VECs, VEGF
19  2016 Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma. ICC, pVEGFR1, rhVEGF, VEGF
20  2016 Distinct iris gene expression profiles of primary angle closure glaucoma and primary open angle glaucoma and their interaction with ocular biometric parameters. ACD, ACV, AS-OCT, LV, PACG, POAG, VEGF
21  2016 Inhibition of AGS Cancer Cell Proliferation following siRNA-Mediated Downregulation of VEGFR2. PCR, RNAi, siRNA, VEGF
22  2016 Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib. EBDC, VEGF
23  2016 Liver Resident Macrophages (Kupffer Cells) Share Several Functional Antigens in Common with Endothelial Cells. KCs
24  2016 Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells. hOMECs, PGE2, VEGF-A
25  2016 Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward? DCs, VEGF
26  2016 Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease. VEGFs
27  2016 Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner. NCL, PTN, VEGF-A
28  2015 Prognostic significance of combining VEGFA, FLT1 and KDR mRNA expression in lung cancer. FLT1, KDR, VEGF
29  2015 Selective Binding of Endostatin Peptide 4 to Recombinant VEGF Receptor 3 In Vitro. ---
30  2015 Vascular endothelial growth factor receptor isoforms: are they present in oral squamous cell carcinoma? OSCC, VEGF
31  2014 Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma. HCC, pVEGFR1, pVEGFR2, VEGF
32  2014 Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway. ERK, PLCG1, VEGF
33  2014 Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming. ER, ESCs, LIF, RTK, VEGFs
34  2014 Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy? PDGF, PVR, VEGF
35  2014 Protection of granulocyte-colony stimulating factor to hemorrhagic brain injuries and its involved mechanisms: effects of vascular endothelial growth factor and aquaporin-4. AQP4, BBB, ERK, G-CSF, ICH, STAT3, VEGF
36  2014 Ramucirumab and its use in gastric cancer treatment. VEGF
37  2013 Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind. VEGFs
38  2013 Functional relevance of the switch of VEGF receptors/co-receptors during peritoneal dialysis-induced mesothelial to mesenchymal transition. MCs, MMT, NRP-1, PD, Sema-3A, VEGF
39  2013 Role of VEGF receptors in normal and psoriatic human keratinocytes: evidence from irradiation with different UV sources. NB-UVB, VEGF
40  2013 Single-chain VEGF/Cy5.5 targeting vegf receptors to indicate atherosclerotic plaque instability. NIRF, scVEGF, VEGF
41  2013 Targeting VEGF signalling via the neuropilin co-receptor. VEGF
42  2013 The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. B-L1P, P-L1B, PlGF, VEGFs
43  2013 The power of VEGF (vascular endothelial growth factor) family molecules. VEGF, VEGFs
44  2013 The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. ---
45  2013 Vascular endothelial growth factor expression in ovarian serous carcinomas and its effect on tumor proliferation. OSCs, VEGF
46  2012 Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma. bFGF, EPCs, SDF-1
47  2012 Activation of VEGFR-2 signaling in response to moderate dose of ultraviolet B promotes survival of normal human keratinocytes. PKC, SFKs, UVB
48  2012 Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system. VEGF
49  2012 Investigational VEGF antagonists for psoriasis. VEGF
50  2012 Mechanisms of resistance to vascular endothelial growth factor blockade. VEGFs
51  2012 Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. PET, VEGF
52  2011 Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies. BTICs, EGFR, GBM, HGF, PDGF, PDGFRs, VEGF
53  2011 Effects of antenatal uteroplacental hypoperfusion on neonatal microvascularisation and excitotoxin sensitivity in mice. IUGR, PD, WM
54  2011 Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas. mMRI, VEGF
55  2011 PEDF regulates vascular permeability by a gamma-secretase-mediated pathway. AJ, PEDF, TJ, VEGF
56  2011 The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE. CEC, CNV, PI3K, RPE
57  2011 Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. NSCs, SVZ, VEGF
58  2011 Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19). ALL, VEGF
59  2010 Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. CRC, EGFR, VEGF
60  2010 Vascular endothelial growth factors and their receptors in the novel human cell line, HN-Eso-1, established from esophageal spindle cell carcinoma. RT-PCR, VEGFs
61  2010 VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. VEGF
62  2009 Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma. MVD, RENCA, VEGF
63  2009 Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. PE, VEGF
64  2009 Expression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence. VEGF
65  2009 Positron emission tomography imaging of poststroke angiogenesis. PET, VEGF
66  2009 Targeting tumor angiogenesis. VEGF
67  2009 Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse. VEGF, VEGFR2
68  2009 [Advances of research on vascular endothelial growth factor receptors in epidermal neoplasm]. VEGF
69  2008 Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. GBM, VEGF
70  2008 High cholesterol feeding in C57/Blc6 mice alters expression within the VEGF receptor-ligand family in corporal tissue. ELISA, PCR, VEGF
71  2008 Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. VEGF121
72  2008 Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. BCG, IC, VEGF
73  2007 Dimerization of VEGF receptors and implications for signal transduction: a computational study. VEGF
74  2007 Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. TGF, VEGF
75  2007 Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. VEGF
76  2007 Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level. AOs, CLS, NAC, VEGF
77  2006 A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis. VEGF
78  2006 Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma. HCC, VEGF
79  2006 Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. flt-1, KDR, NSCLC, VEGF
80  2006 Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions. VEGF
81  2005 C-reactive protein decreases expression of VEGF receptors and neuropilins and inhibits VEGF165-induced cell proliferation in human endothelial cells. CRP, HCAECs
82  2005 Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling. BAEC, eNOS, siRNA, VEGF, VEGFR
83  2004 Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Ang-1, EC
84  2004 Expression and regulation of neuropilins and VEGF receptors by TNF-alpha in human endothelial cells. Ct, ECs, HUVECs, NRPs
85  2004 Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease. HP, PDGFRs, VEGF
86  2004 Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. MAPK, SCLC, VEGFs
87  2004 Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines. VEGF-A
88  2003 Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors. VEGF
89  2003 Dermatomyositis with peripheral nervous system involvement: activation of vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) in vasculitic lesions. DM, VEGF, VEGFR
90  2003 Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma. HNSCC, VECs, VEGF
91  2001 Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. EC, VEGF
92  2001 Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. VEGF
93  2000 Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. HIF-1, VEGF
94  2000 VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. P-Sp, VEGFs
95  1999 Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. DT, VEGF
96  1998 Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina. ROP, VEGF
97  1998 Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). VEGF-D
98  1995 Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. ECs, VEGF, VPS